Boston Scientific (NYSE: BSX) has received U.S. Food and Drug Administration (FDA) approval for the SYNERGY™ Bioabsorbable Polymer Drug-Eluting Stent System (BP-DES) for the treatment of coronary artery disease.
With this FDA approval, Boston Scientific will commence commercialization of the first and only BP-DES in the U.S. Notably, both the drug coating and the polymer – which modulates drug release – are fully absorbed shortly after drug elution is complete at three months.
The SYNERGY Stent provides synchronized drug and polymer absorption. It is designed to enable more rapid and complete arterial healing, and to thereby reduce the risk of complications associated with long-term polymer exposure compared to currently-used drug-eluting stents (DES) with permanent polymers.
To view the multimedia release go to:
http://www.multivu.com/players/English/7223456-boston-scientific-fda-approval-synergy/
The Cancer Effect is the inspiring true story of one woman’s journey with cancer, written to provide hope and healing for patients, survivors, and those who love them. Moving, enlightening, uplifting, and honest. Learn more about this powerful memoir at www.claudiabretzing.com Non-fiction/self help
http://www.legalenglish.com
Dena Falken, a lifelong Christian Scientist discusses a healing of a burn, by relying on Christian Science healing.
Une brulure qui ne laisse aucune trace
Therapy thrives on uninterrupted connection. MTS mental health transcription service captures sessions in real time, keeping conversations flowing while building structured records that support care. With HIPAA safeguards and specialty-trained transcriptionists, MTS delivers more than transcripts — we deliver the written memory of healing, the structure that keeps therapy personal, precise, and progressive.
